156 related articles for article (PubMed ID: 30340897)
1. Synthesis, in vitro and in vivo evaluation of 2-aryl-4H-chromene and 3-aryl-1H-benzo[f]chromene derivatives as novel α-glucosidase inhibitors.
Spasov AA; Babkov DA; Osipov DV; Klochkov VG; Prilepskaya DR; Demidov MR; Osyanin VA; Klimochkin YN
Bioorg Med Chem Lett; 2019 Jan; 29(1):119-123. PubMed ID: 30340897
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, and In Vitro and In Silico α-Glucosidase Inhibitory Studies of 5-Chloro-2-Aryl Benzo[d]thiazoles.
Shah S; Arshia ; Javaid K; Zafar H; Mohammed Khan K; Khalil R; Ul-Haq Z; Perveen S; Iqbal Choudhary M
Bioorg Chem; 2018 Aug; 78():269-279. PubMed ID: 29614438
[TBL] [Abstract][Full Text] [Related]
3. Towards multi-target antidiabetic agents: In vitro and in vivo evaluation of 3,5-disubstituted indolin-2-one derivatives as novel α-glucosidase inhibitors.
Klochkov VG; Bezsonova EN; Dubar M; Melekhina DD; Temnov VV; Zaryanova EV; Lozinskaya NA; Babkov DA; Spasov AA
Bioorg Med Chem Lett; 2022 Jan; 55():128449. PubMed ID: 34780899
[TBL] [Abstract][Full Text] [Related]
4. α-Glucosidase inhibition by flavonoids: an in vitro and in silico structure-activity relationship study.
Proença C; Freitas M; Ribeiro D; Oliveira EFT; Sousa JLC; Tomé SM; Ramos MJ; Silva AMS; Fernandes PA; Fernandes E
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1216-1228. PubMed ID: 28933564
[TBL] [Abstract][Full Text] [Related]
5. Discovery of novel 6-(piperidin-1-ylsulfonyl)-2H-chromenes targeting α-glucosidase, α-amylase, and PPAR-γ: Design, synthesis, virtual screening, and anti-diabetic activity for type 2 diabetes mellitus.
Thabet HK; Abusaif MS; Imran M; Helal MH; Alaqel SI; Alshehri A; Mohd AA; Ammar YA; Ragab A
Comput Biol Chem; 2024 Aug; 111():108097. PubMed ID: 38772048
[TBL] [Abstract][Full Text] [Related]
6. Hetarylcoumarins: Synthesis and biological evaluation as potent α-glucosidase inhibitors.
Chaudhry F; Choudhry S; Huma R; Ashraf M; Al-Rashida M; Munir R; Sohail R; Jahan B; Munawar MA; Khan MA
Bioorg Chem; 2017 Aug; 73():1-9. PubMed ID: 28521172
[TBL] [Abstract][Full Text] [Related]
7. α-Glucosidase inhibitory activity, molecular docking, QSAR and ADMET properties of novel 2-amino-phenyldiazenyl-4H-chromene derivatives.
Perumal O; Peddakotla SVK; Suresh L; Chandramouli GVP; Pydisetty Y
J Biomol Struct Dyn; 2017 Sep; 35(12):2620-2630. PubMed ID: 27555333
[No Abstract] [Full Text] [Related]
8. Synthesis and biological evaluation of novel 1,2,4-triazine derivatives bearing carbazole moiety as potent α-glucosidase inhibitors.
Wang G; Wang J; He D; Li X; Li J; Peng Z
Bioorg Med Chem Lett; 2016 Jun; 26(12):2806-2809. PubMed ID: 27177827
[TBL] [Abstract][Full Text] [Related]
9. Novel pyridine-2,4,6-tricarbohydrazide thiourea compounds as small key organic molecules for the potential treatment of type-2 diabetes mellitus: In vitro studies against yeast α- and β-glucosidase and in silico molecular modeling.
Rehman TU; Riaz S; Khan IU; Ashraf M; Bajda M; Gawalska A; Yar M
Arch Pharm (Weinheim); 2018 Jan; 351(1):. PubMed ID: 29194730
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, in vitro α-glucosidase inhibitory activity and docking studies of novel chromone-isatin derivatives.
Wang G; Chen M; Qiu J; Xie Z; Cao A
Bioorg Med Chem Lett; 2018 Jan; 28(2):113-116. PubMed ID: 29208524
[TBL] [Abstract][Full Text] [Related]
11. α-Glucosidase inhibition and antihyperglycemic activity of flavonoids from Ampelopsis grossedentata and the flavonoid derivatives.
Chen J; Wu Y; Zou J; Gao K
Bioorg Med Chem; 2016 Apr; 24(7):1488-94. PubMed ID: 26922036
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, biological evaluation and molecular docking studies of chromone hydrazone derivatives as α-glucosidase inhibitors.
Wang G; Chen M; Wang J; Peng Y; Li L; Xie Z; Deng B; Chen S; Li W
Bioorg Med Chem Lett; 2017 Jul; 27(13):2957-2961. PubMed ID: 28506754
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, α-glucosidase inhibitory, cytotoxicity and docking studies of 2-aryl-7-methylbenzimidazoles.
Taha M; Ismail NH; Imran S; Mohamad MH; Wadood A; Rahim F; Saad SM; Rehman AU; Khan KM
Bioorg Chem; 2016 Apr; 65():100-9. PubMed ID: 26894559
[TBL] [Abstract][Full Text] [Related]
14. Novel pyridine-2,4,6-tricarbohydrazide derivatives: design, synthesis, characterization and in vitro biological evaluation as α- and β-glucosidase inhibitors.
Riaz S; Khan IU; Yar M; Ashraf M; Rehman TU; Shaukat A; Jamal SB; Duarte VCM; Alves MJ
Bioorg Chem; 2014 Dec; 57():148-154. PubMed ID: 25462991
[TBL] [Abstract][Full Text] [Related]
15. In search of new α-glucosidase inhibitors: Imidazolylpyrazole derivatives.
Chaudhry F; Naureen S; Huma R; Shaukat A; Al-Rashida M; Asif N; Ashraf M; Munawar MA; Khan MA
Bioorg Chem; 2017 Apr; 71():102-109. PubMed ID: 28160945
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel flavonoid alkaloids as α-glucosidase inhibitors.
Zhen J; Dai Y; Villani T; Giurleo D; Simon JE; Wu Q
Bioorg Med Chem; 2017 Oct; 25(20):5355-5364. PubMed ID: 28797772
[TBL] [Abstract][Full Text] [Related]
17. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
Riaz S; Khan IU; Bajda M; Ashraf M; Qurat-Ul-Ain ; Shaukat A; Rehman TU; Mutahir S; Hussain S; Mustafa G; Yar M
Bioorg Chem; 2015 Dec; 63():64-71. PubMed ID: 26451651
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of novel coumarin thiazole derivatives as α-glucosidase inhibitors.
Wang G; He D; Li X; Li J; Peng Z
Bioorg Chem; 2016 Apr; 65():167-74. PubMed ID: 26964016
[TBL] [Abstract][Full Text] [Related]
19. A new entry into the portfolio of α-glucosidase inhibitors as potent therapeutics for type 2 diabetes: Design, bioevaluation and one-pot multi-component synthesis of diamine-bridged coumarinyl oxadiazole conjugates.
Kazmi M; Zaib S; Ibrar A; Amjad ST; Shafique Z; Mehsud S; Saeed A; Iqbal J; Khan I
Bioorg Chem; 2018 Apr; 77():190-202. PubMed ID: 29421697
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, in vitro evaluation and molecular docking studies of biscoumarin thiourea as a new inhibitor of α-glucosidases.
Zawawi NK; Taha M; Ahmat N; Ismail NH; Wadood A; Rahim F; Rehman AU
Bioorg Chem; 2015 Dec; 63():36-44. PubMed ID: 26432614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
